Auxilium Pharmaceuticals has signed an agreement with UK-based Cobra Biologics to manufacture additional cGMP and BLA batches for AA4500. The companies anticipate that this manufacturing activity will be completed by the end of 2006. The agreement does not cover long-term production of AA4500 for commercial sale, but the companies will be discussing a non-exclusive long-term supply agreement for AA4500 during the second half of 2006....